{
  "@type": "NewsArticle",
  "identifier": "2022--03--22--en--myrss--dhruv-khullar--NewsArticle--dd9434663f1c44c69037b3a1d1e3e56c",
  "url": "https://www.newyorker.com/science/annals-of-medicine/are-we-about-to-cure-sickle-cell-disease",
  "headline": "Are We About to Cure Sickle-Cell Disease?",
  "publisher": {
    "@type": "Organization",
    "name": "www.newyorker.com",
    "url": "https://www.newyorker.com/feed/news"
  },
  "description": "New gene therapies hold extraordinary promise, but they might not be enough to overcome a medical system that marginalizes Black Americans.",
  "keywords": [],
  "author": {
    "@type": "Person",
    "name": "Dhruv Khullar",
    "url": "https://www.newyorker.com/feed/news"
  },
  "discussionUrl": "https://www.newyorker.com/science/annals-of-medicine/are-we-about-to-cure-sickle-cell-disease",
  "sameAs": "https://www.newyorker.com/science/annals-of-medicine/are-we-about-to-cure-sickle-cell-disease",
  "dateCreated": "2022-03-22T10:33:15.675Z",
  "datePublished": "2022-03-22T10:00:00.000Z",
  "dateModified": "2022-03-22T10:33:15.675Z",
  "interactionStatistic": [],
  "headline_zh-Hans": "我们即将治愈镰状细胞病吗？",
  "headline_zh-Hant": "我們即將治癒鐮狀細胞病嗎？",
  "@context": [
    "https://schema.org",
    {
      "@vocab": "http://schema.org/",
      "@language": "en",
      "headline_zh-Hans": {
        "@id": "headline",
        "@language": "zh-Hans"
      },
      "headline_zh-Hant": {
        "@id": "headline",
        "@language": "zh-Hant"
      },
      "@version": 1.1,
      "description_zh-Hans": {
        "@id": "description",
        "@language": "zh-Hans"
      },
      "description_zh-Hant": {
        "@id": "description",
        "@language": "zh-Hant"
      }
    }
  ],
  "description_zh-Hans": "新的基因疗法有着非凡的前景，但它们可能不足以克服将美国黑人边缘化的医疗体系。",
  "description_zh-Hant": "新的基因療法有著非凡的前景，但它們可能不足以克服將美國黑人邊緣化的醫療體系。"
}